HRSA/MCHB Newborn Screening Systematic Evidence Review IDIQ and Task Order 1

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

HRSA HEADQUARTERS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75R60226R00026

NAICS

541690 - Other Scientific and Technical Consulting Services

Classification Code

R499

Additional Details
Set Aside

None

Place of Performance

Maryland, UNITED STATES

SourceSAM
The Health Resources and Services Administration (HRSA), operating under the Department of Health and Human Services, has announced the award of a competitive, full and open Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract for the provision of highly specialized scientific methodologies, systematic clinical evidence reviews, and core programmatic support related to the Newborn Screening Recommended Uniform Screening Panel (RUSP). This procurement, identified under solicitation number 75R60226R00026, was initially issued as a Multiple-Award IDIQ; however, after a thorough evaluation of proposals, a single award has been made. The scope of this contract encompasses the delivery of expert scientific and technical consulting services, as classified under NAICS code 541690 (Other Scientific and Technical Consulting Services) and Product Service Code R499. The primary objective is to support HRSA’s Maternal and Child Health Bureau (MCHB) in conducting systematic evidence reviews that inform updates and recommendations for the RUSP, which is a critical component of the national newborn screening program. The intended outcomes include the generation of rigorous, evidence-based assessments to guide policy and practice in newborn screening, thereby enhancing public health outcomes for infants across the United States. The contract vehicle carries a maximum cumulative ceiling value of $15,111,361.10, ensuring substantial capacity for ongoing and future task orders. Concurrent with the award of the parent IDIQ, the initial Task Order (Task Order 1) has been executed in the amount of $1,993,225.49. This initial task order satisfies the contract’s minimum guarantee and marks the commencement of performance under the contract. The place of performance for this contract is Maryland, United States. The contracting activity is managed by HRSA Headquarters, with primary and secondary points of contact being Shawn Horton ([email protected]) and Elizabeth Van Absher ([email protected]), respectively. This award notice is for informational purposes only and does not constitute a solicitation for proposals or additional offers. Contractors interested in similar opportunities should note that this is a post-award announcement, and no further solicitations are being requested at this time. Key elements that will remain constant throughout the contract lifecycle include the focus on systematic evidence reviews, the provision of specialized scientific consulting services, and the support of HRSA’s mission to advance newborn screening practices. The contract is not set aside for any specific socioeconomic category and was competed on a full and open basis, reflecting HRSA’s commitment to engaging the most qualified entities for this critical public health initiative. For further details, interested parties may refer to the official notice on SAM.gov (Opportunity ID: 3b13b7f8e4e04e1e81c5ec7a45139ff5) or contact the designated HRSA representatives.